Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Heart attack drug shows promise for microvascular damage

NCT ID NCT07380919

First seen Feb 02, 2026 · Last updated May 23, 2026 · Updated 18 times

Summary

This study tests whether the drug ranolazine can protect the tiny blood vessels in the heart after a major heart attack. Researchers will enroll 100 adults who have had a specific type of heart attack (STEMI) and have blockages in multiple arteries. Participants will either receive ranolazine or standard care, and their heart vessel function will be measured over several weeks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STEMI (ST ELEVATION MI) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of Cardiology, Santa Maria Goretti Hospital, Latina, Italy

    NOT_YET_RECRUITING

    Latina, Italy, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Department of Medical and Surgical Sciences and "Renato Dulbecco" University Hospital, "Magna Graecia" University

    RECRUITING

    Catanzaro, Italy, 88100, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Federico II University Hospital - Division of Cardiology

    RECRUITING

    Naples, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.